Evidence map›Paper›PMID 29881409›Full record

ArticleIranian journal of pharmaceutical research : IJPR2018

Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors.

Ahmed Abdelfattah Hafez Abdellatif, Wael Abdellah Abdelhafez, Hatem Abdelmunsef Sarhan

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03774680 (Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue for Targeting of Colon Cancer), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03774680 phase1unknown statusnot on this mapstarted 2020, after this paper: background citation

Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue for Targeting of Colon Cancer

TypeinterventionalSponsorAhmed A. H. AbdellatifRan2020 to 2021Enrolled30ConditionsColon Cancer, Colo-rectal CancerArmsCetuximab nanoparticles, Oral approved anticancer drug
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Targeting of somatostatin receptors expressed in blood cells using quantum dots coated with vapreotide.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ahmed Abdelfattah Hafez AbdellatifDepartment of Pharmaceutics and Industrial pharmacy, Faculty of Pharmacy, Al-Azhar University, Assuit, Egypt.
Wael Abdellah AbdelhafezDepartment of Pharmaceutics and Industrial pharmacy, Faculty of Pharmacy, Al-Azhar University, Assuit, Egypt.
Hatem Abdelmunsef SarhanDepartment of Pharmaceutics and Industrial pharmacy, Faculty of Pharmacy, El-Minia University, El-Minia, Egypt.
Al-Azhar University · EGMinia University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the unique optical properties like high brightness and narrow emission bands of Quantum dots, it is used as simple fluorescence materials in bio-imaging, immunoassays, microarrays, and other applications. To easy invistigate cell lines that overexpressed somtostatin receptors, somatostatin (SST) was conjugated with Quantum dots carrying PEG amine (Qdots-PEG-NH

Indexed as

Cellular uptakeQuantum dotsReceptor targetingSomatostatinSomatostatin receptors

Identifiers

PMID29881409
PMCPMC5985169
OpenAlexW2787725813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.